Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia
NCT ID: NCT03630276
Last Updated: 2018-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
111 participants
INTERVENTIONAL
2018-08-01
2018-08-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of neutrophil-to Lymphocyte Ratio in Preeclampsia- Eclampsia
NCT01856387
Prevalence of Antiphospholipid Antibodies Among Women With Preeclampsia
NCT02699437
Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester
NCT02990767
CA-125 and Severity of Pre-Eclampsia
NCT02704676
Study of Association Between Maternal Uric Acid , Maternal and Fetal Outcome in Pregnant Women With Hypertension
NCT01523327
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neutrophil/lymphocyte ratio
Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP
Lab
Platelet/lymphocyte ratio
Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP
Lab
CRP
Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP
Lab
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP
Lab
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
25 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shaza Mohamed Elreweny
Shaza Mohamed Elreweny
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shaza
Alexandria, Alex, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Shaza Elreweny
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.